STUDY QUESTION: What is the association between the ovarian response and the number of CGG repeats among full mutation and premutation carriers of fragile X (FMR1), undergoing controlled ovarian hyperstimulation (COH) for PGD?
MAIN RESULTS AND THE ROLE OF CHANCE: Premutation carriers displayed reduced ovarian response, as demonstrated by fewer oocytes retrieved. In contrast, full mutation patients had a normal response. Comparison of premutation carriers and full mutation patients showed: mean oocytes retrieved per cycle (8.4 ± 1.1 versus 14.1 ± 1.7, P = 0.005), lower levels of estradiol (E2; 1756 ± 177, versus 2928 ± 263, P = 0.0004), respectively. There was no significant difference between premutation carriers and full mutation patients in regard to fertilization rate, cleavage rate or biopsy rate. No correlation was found between the number of repeats in the premutation carriers and the number of oocytes retrieved or E2 levels. Age and the type of protocol were the only factors found to be in correlation with the number of the oocyte retrieved (P = 0.037, and P = 0.003, respectively) among the premutation carriers. Similarly, no association was found between the number of repeats and the fertilization rate, cleavage rate or biopsy rate among premutation carriers.
LIMITATIONS, REASONS FOR CAUTION:
We had a relatively low number of premutation carriers with >100 repeats, which made it challenging to draw a firm conclusions from this group.
Introduction
Fragile X syndrome (FXS) is one of the most common heritable forms of intellectual and developmental disability, affecting males and some of the females with a full mutation on the FMR1 gene, defined as >200 repeats of CGG in the 5′ region of the gene. Repeats in the range of 55-199 are defined as premutation, and are prone to expansion in descendants of female carriers (Pastore and Johnson, 2014) . Growing evidence suggests that premutation carriers are at risk for reduced ovarian function and early loss of fertility. Regardless of CGG repeats number, carriers are in increased risk for primary ovarian insufficiency (POI) as a group. However, there are still some gaps in our knowledge in regard to onset, prevalence, severity of infertility and the association to the number of repeats, which make reproductive counseling challenging (Wittenberger et al., 2007) .
In the current literature, the highest risk for ovarian dysfunction is described in mid-range repetitions. Sullivan et al. (2005) suggested the ranges of 80-99 repeats as a primary significant risk factor for ovarian dysfunction while others (Ennis et al., 2006 ) demonstrated higher risk for ovarian dysfunction at a nadir of 80 repeats.
PGD offers carrier couples an option to avoid the birth of an affected offspring. It was suggested that PGD may be challenging for carriers of fragile X premutation due to the higher doses of FSH needed for ovarian stimulation and a possible lower embryo quality (Platteau et al., 2002) . Elizur et al. (2014) studied 21 FMR1 premutation carriers in their IVF-PGD unit. They suggested that the diminished ovarian function that occurs among carriers in the ranges of 80-120 repeats is due to increased granulosa cell FMR1 mRNA accumulation.
In a previous study (Bibi et al., 2010) , there was a linear association between the number of repeats and the number of oocytes aspirated. The number of oocyte retrieved was higher and dosage of gonadotropin was lower in patients with >100 CGG repeats compared with those with fewer than 100 repeats.
There is inconsistent data in the literature regarding ovarian response in FMR1 carriers and to the best of our knowledge, studies exploring the ovarian response of full mutation patients are lacking.
Our aim was aimed to assess possible correlation between the number of repeats and ovarian response in premutation carriers and full mutation patients.
Materials and Methods
The research was undertaken in a university affiliated tertiary hospital and was approved by the local Institutional Review Board. Patients were referred to our unit after genetic consultation either following a national prenatal screening program test that identified them as premutation or full mutation carriers, or due to a family history of FXS. We recorded demographic and obstetrical data of the patients, stimulation protocol, dosage of gonadotrophins, maximal E2 levels, number of oocytes retrieved, number of oocytes fertilized, number of cleaved embryos and the number of embryos biopsied for diagnosis. The study includes 14 premutation patients and four full mutation patients from our prior study (Bibi et al., 2010) .
We defined normal ovarian response as retrieving 10 or more oocytes in controlled ovarian stimulation for IVF-PGD cycle in accordance with the current literature (Nelson, 2013) .
Statistical analysis
As there were multiple cycles per woman, data were analyzed using mixed models with random effects as intercepts for the patients. To examine differences in number of oocytes, estrogen levels, age and FSH dose between premutation carriers and patients with full mutation, a mixed model was performed for each examined variable. In order to evaluate whether a correlation exists between the number of CGG repeats and the ovarian response we used a multivariate mixed model. Number of CGG repeats, age, type of protocol used and FSH dosage were included in the model as possible predictors for ovarian response. Due to the long period analyzed and to account for potential confounding effect of changes with time, we also included the year as a variable in the model. Similar analysis was also used to asses possible relation of CGG repeats with fertilization rate, cleavage rate and biopsy rate. Visual inspection of residual plots was done to examine deviations from homoscedasticity or normality. P-values were obtained by likelihood ratio tests of the full model with the effect in question against the model without the effect in question. To evaluate previously reported trends, we examined quadratic transformation on the number of CGG repeats for possible non-linear effects (Ennis et al., 2006; Elizur et al., 2014) , and categorization of number of repeats (Sullivan et al., 2005; Bibi et al., 2010) . Bayesian information criteria (BIC) was used to decide if these additional variables improve the model.
Results
Data were collected from medical records of 72 patients. Of these, 21 with a full mutation on the FMR1 gene and 51 premutation carriers. Overall 309 fresh cycles were analyzed. Patient characteristics comparison between premutation carriers and full mutation is presented in Table I . The values in the Table represent the estimated expected variable according to the mixed model for each of the two groups. There was no difference in the age of the patients in the two groups. Premutation carriers displayed reduced ovarian response compared to full mutation patients, as was evident by lower mean oocytes retrieved per cycle (8.4 ± 1.1, 14.1 ± 1.7, P = 0.005) and lower levels of E2 (pg/ml) (1756 ± 177, 2928 ± 263, P = 0.0004). Additionally, premutation carriers required higher doses of gonadotropins compared to the full mutations patients, however, the difference was not statistically significant (3561 ± 200, 2960 ± 303, P = 0.1). Figure 1 represents the association between the number of CGG repeats and the number of oocytes retrieved for premutation carriers. The multivariate mixed model analysis for premutation carriers required a square root transformation on the number of oocytes, in order to reduce heteroscedasticity. The model showed no association between the number of CGG repeats and the square root of number of oocytes retrieved (P = 0.17). Younger age and the agonist protocol were the only factors correlated to increased number of the oocytes retrieved (P = 0.037 and P = 0.003, respectively). Similarly, no association was found between the number of repeats and the fertilization rate, cleavage rate or biopsy rate among premutation carriers. Adding quadratic transformation on the number of CGG repeats did not improve the model (based on the BIC). Adding a dummy variable that categorized the number of repeats into three groups (<80, 80-99 and >99 repeats) or two groups (<100, ≥100 repeats) did not improve the model either.
Discussion
We found that full mutation patients have normal ovarian response for gonadotropins stimulation. To the best of our knowledge, this was not previously investigated or published. Notwithstanding, premutation carriers had a lower number of oocytes retrieved and lower E2 levels. It is in concordance with the previously described tendency for early ovarian insufficiency among fragile X premutation carriers (Welt et al., 2004; Lisik, 2007; Spath et al., 2011) . However, unlike previous reports we did not find a statistical model that accurately describes possible association between the number of CGG repeats and the ovarian response.
The literature concerning the ovarian response in premutation carriers is inconsistent.
While in a prior study (Bibi et al., 2010) , with a small subset of the patients in the current study, we demonstrated a linear association with improved ovarian response at higher numbers of CGG repeats, Elizur et al. (2014) demonstrated a nadir of the ovarian response in the midrange of 80-120 repeats. They postulated that this reduction in response was due to the increased granulosa cells FMR1 mRNA accumulation. Rohr et al. (2008) , showed an association between a higher repeat allele (defined as above 70) and a lower ovarian reserve as indicated by lower AMH levels. Another work that tangles the possibility of a straight explanation, analyzed blood samples from premutation carriers (Tejada et al., 2008) . They demonstrated that the likelihood of having POF was higher with fewer than 100 CGG repeats.
The exact mechanism of ovarian insufficiency in premutation carriers is not understood. It is clear that although the chances to suffer from reduction in ovarian function and POI are higher in permutation carriers, as a group, most of them stay unaffected.
Our study, in agreement with the mixed results from former studies, did not find a relationship between the exact number of repeats and the ovarian response. Our results also failed to show reduced embryo quality as was reflected by similar biopsy rates, and as opposed to previously suggested (Platteau et al., 2002) Figure 1 Boxplot describing the number of retrieved oocytes in relation to the number of repeats in premutation carriers (including 51 patients with 206 oocytes cycles). The dark lines represent the medians, the boxes represent the first and third quartile, and the whiskers extend to ±1.58 interquartile range divided by the square root of the sample size; this roughly gives a 95% CI for the difference in medians. The circles represent the outliers, i.e. values that are beyond the whiskers.
We studied, to the best of our knowledge, the largest cohort of premutation carriers undergoing controlled ovarian hyperstimulation (COH)-PGD.
Our study has a few limitations. First, the inherent flaws of a retrospective study, including possible lack of power that may have result a failure to establish significance of some variables. Second, we had a relatively low number of premutation carriers with >100 repeats, which made it challenging to draw firm conclusions from this group. Yet, it is possible that this reflects the lower proportion of premutation carriers with >100 repeats out of all premutation carriers.
In conclusion, our study found no concordance between the exact number of CGG repeats and the ovarian response during COH among premutation carriers. However, we did show a normal ovarian response among full mutation patients. Additionally, we found a reduced ovarian response among premutation carriers compared to full mutation patients. The molecular explanation for the last necessitates further research. In the meantime, physicians must address the increased risk for reduced ovarian response during fertility treatments and POI among carriers and consider surveillance of ovarian reserve markers. The last, might expedite family plans completion or fertility preservation.
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